Oncology Today with Dr Neil Love
By Dr. Neil Love
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Dr. Neil Love
Category: Science
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 15
Reviews: 0
Episodes: 534
Description
Medical oncologist Dr Neil Love interviews clinical investigators on new research and practical application to general medical oncology practice.
| Episode | Date |
|---|---|
|
Chronic Lymphocytic Leukemia — Microlearning Activity 2
|
Oct 16, 2026 |
|
Chronic Lymphocytic Leukemia — Microlearning Activity 1
|
Oct 15, 2026 |
|
Ovarian Cancer — Microlearning Activity 2: Proceedings from an Independent Satellite Symposium during the SGO Annual Meeting on Women's Cancer
|
Oct 14, 2026 |
|
Ovarian Cancer — Microlearning Activity 1: Proceedings from an Independent Satellite Symposium during the SGO Annual Meeting on Women's Cancer
|
Oct 13, 2026 |
|
Relapsed/Refractory Multiple Myeloma — Proceedings from a Session Held During the Society of Hematologic Oncology 2026 Annual Meeting
|
Oct 12, 2026 |
|
Metastatic Triple-Negative Breast Cancer — 5-Minute Journal Club Activity 4 with Dr Sara M Tolaney
|
Oct 10, 2026 |
|
Metastatic Triple-Negative Breast Cancer — 5-Minute Journal Club Activity 3 with Dr Sara M Tolaney
|
Oct 09, 2026 |
|
Chronic Lymphocytic Leukemia — Investigators Discuss Optimal Management
|
Oct 08, 2026 |
|
HER2-Positive Gynecologic Cancers — Microlearning Activity 3: Proceedings from an Independent Satellite Symposium during the SGO Annual Meeting on Women's Cancer
|
Oct 07, 2026 |
|
Diffuse Large B-Cell Lymphoma — An Interview with Dr L Elizabeth Budde on Employing CD20 x CD3 Bispecific Antibodies
|
Oct 05, 2026 |
|
Lung Cancer — Proceedings from a Symposium Held in Conjunction with the American Oncology Network
|
Oct 04, 2026 |
|
Prostate Cancer with PTEN Deficiency — An Interview with Dr Neeraj Agarwal
|
Oct 02, 2026 |
|
HER2-Positive Gynecologic Cancers — Microlearning Activity 2: Proceedings from an Independent Satellite Symposium during the SGO Annual Meeting on Women's Cancer
|
Oct 01, 2026 |
|
Diffuse Large B-Cell Lymphoma — Proceedings from a Symposium Held in Conjunction with the American Oncology Network
|
Oct 01, 2026 |
|
Ovarian and Endometrial Cancer — Proceedings from a Symposium Held in Conjunction with the American Oncology Network
|
Oct 01, 2026 |
|
For Oncology Nurses: Non-Small Cell Lung Cancer with a ROS1 Fusion — An Interview with Dr Alexander E Drilon
|
Sep 30, 2026 |
|
Glucocorticoid Receptor Antagonists for Ovarian Cancer — An Interview with Professor Nicoletta Colombo
|
Sep 29, 2026 |
|
Gastroesophageal Cancers — Proceedings from a Symposium Held in Conjunction with the American Oncology Network
|
Sep 28, 2026 |
|
Chronic Lymphocytic Leukemia — Proceedings from a Symposium Held in Conjunction with the American Oncology Network
|
Sep 28, 2026 |
|
Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia — Reviewing Recent Datasets from the 2026 ASCO Annual Meeting and EHA2026 Congress
|
Sep 25, 2026 |
|
HER2-Positive Gynecologic Cancers — Microlearning Activity 1: Proceedings from an Independent Satellite Symposium during the SGO Annual Meeting on Women's Cancer
|
Sep 24, 2026 |
|
Antibody-Drug Conjugates for Multiple Myeloma — An Interview with Dr Douglas W Sborov
|
Sep 23, 2026 |
|
Metastatic Triple-Negative Breast Cancer — 5-Minute Journal Club Activity 2 with Dr David W Cescon
|
Sep 22, 2026 |
|
Metastatic Triple-Negative Breast Cancer — 5-Minute Journal Club Activity 1 with Dr David W Cescon
|
Sep 21, 2026 |
|
Gynecologic Cancers — Reviewing Key Presentations from the 2026 ASCO Annual Meeting
|
Sep 17, 2026 |
|
Metastatic Bladder Cancer — Rapid Case Review Issue 8
|
Sep 16, 2026 |
|
Metastatic Bladder Cancer — Rapid Case Review Issue 7
|
Sep 16, 2026 |
|
Breast Cancer — Reviewing Key Presentations from the 2026 ASCO Annual Meeting
|
Sep 15, 2026 |
|
Low-Grade Serous Ovarian Cancer — Rapid Case Review: Microlearning Activity 2
|
Sep 14, 2026 |
|
Low-Grade Serous Ovarian Cancer — 5-Minute Journal Club: Microlearning Activity 1
|
Sep 13, 2026 |
|
Chronic Myeloid Leukemia — An Interview with Prof Andreas Hochhaus
|
Sep 11, 2026 |
|
Endometrial Cancer — Microlearning Activity 3: Proceedings from an Independent Satellite Symposium during the SGO Annual Meeting on Women's Cancer
|
Sep 11, 2026 |
|
Non-Small Cell Lung Cancer — Targeting KRAS G12C
|
Sep 10, 2026 |
|
Prostate Cancer — The Optimal Use of Hormonal Therapy
|
Sep 08, 2026 |
|
Chronic Lymphocytic Leukemia — Rapid Case Review: Microlearning Activity 4
|
Sep 07, 2026 |
|
Chronic Lymphocytic Leukemia — 5-Minute Journal Club: Microlearning Activity 3
|
Sep 06, 2026 |
|
AKT Inhibition in Prostate Cancer — Microlearning Activity 3: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium
|
Sep 05, 2026 |
|
ER-Positive, HER2-Positive Metastatic Breast Cancer — Patterns of Care Among Community Oncologists
|
Sep 03, 2026 |
|
Relapsed/Refractory Chronic Lymphocytic Leukemia — A Grand Rounds Program
|
Sep 02, 2026 |
|
Lambert-Eaton Myasthenic Syndrome in Small Cell Lung Cancer — An Interview with Prof Ticiana Leal
|
Sep 01, 2026 |
|
For Oncology Nurses: Prostate Cancer — Proceedings from the 2026 Annual ONS Congress
|
Aug 31, 2026 |
|
Metastatic Triple-Negative Breast Cancer — Patterns of Care
|
Aug 28, 2026 |
|
Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Microlearning Activity 4: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium
|
Aug 27, 2026 |
|
Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Microlearning Activity 3: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium
|
Aug 26, 2026 |
|
Non-Hodgkin Lymphoma — Year in Review Series on Relevant New Datasets and Advances
|
Aug 25, 2026 |
|
For Oncology Nurses: Pancreatic Cancer — Proceedings from the 2026 Annual ONS Congress
|
Aug 24, 2026 |
|
HR-Positive Metastatic Breast Cancer — Year in Review Series on Relevant New Datasets and Advances in the PI3K/AKT/mTOR Pathway
|
Aug 23, 2026 |
|
AKT Inhibition in Prostate Cancer — Microlearning Activity 2: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium
|
Aug 22, 2026 |
|
AKT Inhibition in Prostate Cancer — Microlearning Activity 1: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium
|
Aug 21, 2026 |
|
Gastroesophageal Cancers — Year in Review Series on Relevant New Datasets and Advances
|
Aug 19, 2026 |
|
Genitourinary Cancers — Reviewing Key Presentations from the 2026 ASCO Annual Meeting
|
Aug 19, 2026 |
|
Metastatic Bladder Cancer — Rapid Case Review Issue 6
|
Aug 18, 2026 |
|
For Oncology Nurses: Oral Selective Estrogen Receptor Degraders in Breast Cancer — Proceedings from the 2026 Annual ONS Congress
|
Aug 18, 2026 |
|
Metastatic Bladder Cancer — Rapid Case Review Issue 5
|
Aug 17, 2026 |
|
Multiple Myeloma — Year in Review Series on Relevant New Datasets and Advances
|
Aug 17, 2026 |
|
Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Microlearning Activity 2: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium
|
Aug 15, 2026 |
|
Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Microlearning Activity 1: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium
|
Aug 14, 2026 |
|
Non-Hodgkin Lymphoma — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting on the Roles of CAR T-Cell Therapy and Bispecific Antibodies
|
Aug 13, 2026 |
|
Prostate Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting
|
Aug 12, 2026 |
|
Myelofibrosis — Proceedings from a Webinar Held in Conjunction with the 2026 ASCO Annual Meeting
|
Aug 11, 2026 |
|
For Oncology Nurses: Targeting the PI3K/AKT/mTOR Pathway in HR-Positive Metastatic Breast Cancer — Proceedings from the 2026 Annual ONS Congress
|
Aug 10, 2026 |
|
Small Cell Lung Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting
|
Aug 07, 2026 |
|
Gastroesophageal Cancers — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting
|
Aug 06, 2026 |
|
Chronic Lymphocytic Leukemia — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting
|
Aug 05, 2026 |
|
Non-Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances in Therapeutic Targets Beyond EGFR
|
Aug 03, 2026 |
|
For Oncology Nurses: Relapsed/Refractory Multiple Myeloma — Proceedings from the 2026 Annual ONS Congress
|
Aug 03, 2026 |
|
TROP2- and CDH6-Directed ADCs in Gynecologic Cancers — An Interview with Dr Ramez Eskander on Key Presentations from the Society of Gynecologic Oncology 2026 Annual Meeting
|
Aug 01, 2026 |
|
HER2-Altered Non-Small Cell Lung Cancer — 5-Minute Journal Club: Microlearning Activity 3
|
Jul 30, 2026 |
|
HER2-Altered Non-Small Cell Lung Cancer — 5-Minute Journal Club: Microlearning Activity 2
|
Jul 30, 2026 |
|
For Oncology Nurses: CDK4/6 Inhibitors for Breast Cancer — Proceedings from the 2026 Annual ONS Congress
|
Jul 29, 2026 |
|
Colorectal Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting
|
Jul 28, 2026 |
|
Chronic Lymphocytic Leukemia — 5-Minute Journal Club: Microlearning Activity 1
|
Jul 27, 2026 |
|
Chronic Lymphocytic Leukemia — Rapid Case Review: Microlearning Activity 2
|
Jul 27, 2026 |
|
Breast Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting on the Use of Oral SERDs and Agents Targeting the PI3K/AKT/mTOR Pathway
|
Jul 25, 2026 |
|
For Oncology Nurses: Ovarian Cancer — Proceedings from the 2026 Annual ONS Congress
|
Jul 23, 2026 |
|
Relapsed/Refractory Multiple Myeloma — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting
|
Jul 22, 2026 |
|
EGFR-Mutated Non-Small Cell Lung Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting
|
Jul 21, 2026 |
|
Endometrial Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting
|
Jul 20, 2026 |
|
HER2-Positive Metastatic Breast Cancer — An Interview with Prof Dr Sibylle Loibl on First-Line and Maintenance Therapy
|
Jul 17, 2026 |
|
For Oncology Nurses: Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia — Proceedings from the 2026 Annual ONS Congress
|
Jul 16, 2026 |
|
Ovarian Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting
|
Jul 15, 2026 |
|
HER2-Altered Non-Small Cell Lung Cancer — Rapid Case Review
|
Jul 14, 2026 |
|
Localized HR-Positive Breast Cancer — Year in Review Series on Relevant New Datasets and Advances
|
Jul 13, 2026 |
|
Endometrial Cancer — Microlearning Activity 2: Proceedings from an Independent Satellite Symposium during the SGO Annual Meeting on Women’s Cancer
|
Jul 12, 2026 |
|
Nonmetastatic Non-Small Cell Lung Cancer — An Interview with Dr Jamie E Chaft
|
Jul 11, 2026 |
|
Endometrial Cancer — Microlearning Activity 1: Proceedings from an Independent Satellite Symposium during the SGO Annual Meeting on Women’s Cancer
|
Jul 10, 2026 |
|
Novel Therapies for Non-Hodgkin Lymphoma — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting
|
Jul 09, 2026 |
|
Antibody-Drug Conjugates in the Management of Breast Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting
|
Jul 08, 2026 |
|
Endometrial Cancer — An Interview with Dr Floor J Backes
|
Jul 07, 2026 |
|
For Oncology Nurses: Antibody-Drug Conjugates — Proceedings from the 2026 Annual ONS Congress
|
Jul 06, 2026 |
|
Androgen Deprivation Therapy for Prostate Cancer — An Interview with Dr Rana R McKay
|
Jul 02, 2026 |
|
For Oncology Nurses: Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Proceedings from the 2026 Annual ONS Congress
|
Jul 01, 2026 |
|
Targeted Therapies for Non-Small Cell Lung Cancer — Fifth Annual National General Medical Oncology Summit
|
Jun 30, 2026 |
|
HR-Positive Breast Cancer — Fifth Annual National General Medical Oncology Summit
|
Jun 29, 2026 |
|
Acute Myeloid Leukemia — Fifth Annual National General Medical Oncology Summit
|
Jun 28, 2026 |
|
Desmoid Tumors and Soft Tissue Sarcoma — Fifth Annual National General Medical Oncology Summit
|
Jun 27, 2026 |
|
EGFR-Mutated Non-Small Cell Lung Cancer — Fifth Annual National General Medical Oncology Summit
|
Jun 27, 2026 |
|
Metastatic Triple-Negative Breast Cancer — What Clinicians Want to Know
|
Jun 26, 2026 |
|
Urothelial Bladder Cancer — Year in Review Series on Relevant New Datasets and Advances
|
Jun 25, 2026 |
|
Myelofibrosis and Systemic Mastocytosis — Fifth Annual National General Medical Oncology Summit
|
Jun 24, 2026 |
|
For Oncology Nurses: Endometrial Cancer — Proceedings from the 2026 Annual ONS Congress
|
Jun 24, 2026 |
|
HER2-Positive Breast Cancer — Fifth Annual National General Medical Oncology Summit
|
Jun 23, 2026 |
|
Prostate Cancer — Fifth Annual National General Medical Oncology Summit
|
Jun 23, 2026 |
|
Colorectal Cancer — Fifth Annual National General Medical Oncology Summit
|
Jun 22, 2026 |
|
Triple-Negative Breast Cancer — Fifth Annual National General Medical Oncology Summit
|
Jun 20, 2026 |
|
Desmoid Tumors — Microlearning Activity 4 with Prof Bernd Kasper
|
Jun 20, 2026 |
|
Ovarian Cancer — Fifth Annual National General Medical Oncology Summit
|
Jun 19, 2026 |
|
Gastroesophageal Cancers — Fifth Annual National General Medical Oncology Summit
|
Jun 19, 2026 |
|
Multiple Myeloma — Fifth Annual National General Medical Oncology Summit
|
Jun 18, 2026 |
|
First-Line and Maintenance Therapy for Patients with Extensive-Stage Small Cell Lung Cancer — An Interview with Prof Martin Reck
|
Jun 18, 2026 |
|
Urothelial Bladder Cancer — Fifth Annual National General Medical Oncology Summit
|
Jun 17, 2026 |
|
HER2-Positive Gynecologic Cancers — Proceedings from a Session Held During the Society of Gynecologic Oncology 2026 Annual Meeting on Women's Cancer
|
Jun 17, 2026 |
|
Chronic Lymphocytic Leukemia — Fifth Annual National General Medical Oncology Summit
|
Jun 16, 2026 |
|
Prostate Cancer — Proceedings from a Session Held in Conjunction with the 2026 American Urological Association Annual Meeting
|
Jun 16, 2026 |
|
Pancreatic Cancer — Fifth Annual National General Medical Oncology Summit
|
Jun 15, 2026 |
|
Diffuse Large B-Cell Lymphoma and Follicular Lymphoma — Fifth Annual National General Medical Oncology Summit
|
Jun 15, 2026 |
|
Localized Renal Cell Carcinoma — Proceedings from a Session Held in Conjunction with the 2026 American Urological Association Annual Meeting
|
Jun 12, 2026 |
|
HR-Positive Metastatic Breast Cancer — A Discussion and Debate on First- and Second-Line Therapy
|
Jun 11, 2026 |
|
Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances
|
Jun 08, 2026 |
|
Genitourinary Cancers — 5-Minute Journal Club Issue 2 with Professor Thomas Powles: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays
|
Jun 05, 2026 |
|
Antibody-Drug Conjugates in Gynecologic Cancers — Proceedings from a Session Held During the Society of Gynecologic Oncology 2026 Annual Meeting on Women's Cancer
|
Jun 03, 2026 |
|
Desmoid Tumors — Microlearning Activity 3 with Prof Bernd Kasper
|
Jun 02, 2026 |
|
Colorectal Cancer — Year in Review Series on Relevant New Datasets and Advances
|
May 28, 2026 |
|
Genitourinary Cancers — 5-Minute Journal Club Issue 1 with Professor Thomas Powles: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays
|
May 26, 2026 |
|
Bruton Tyrosine Kinase Inhibitors for Chronic Lymphocytic Leukemia — Year in Review Series on Relevant New Datasets and Advances
|
May 23, 2026 |
|
Ovarian Cancer — Proceedings from a Session Held During the Society of Gynecologic Oncology 2026 Annual Meeting on Women’s Cancer
|
May 21, 2026 |
|
Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancers — Microlearning Activity 4: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium
|
May 20, 2026 |
|
PARP Inhibitors for Patients with Hormone-Sensitive and Castration-Resistant Metastatic Prostate Cancer — An Interview with Dr Wassim Abida
|
May 15, 2026 |
|
Immunotherapy for Endometrial Cancer — Proceedings from a Session Held During the Society of Gynecologic Oncology 2026 Annual Meeting on Women’s Cancer
|
May 14, 2026 |
|
Oncology Nursing Update: Nonmelanoma Skin Cancers — An Interview with Dr Nikhil Khushalani
|
May 07, 2026 |
|
Localized Colorectal Cancer — Microlearning Activity 3: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium
|
May 03, 2026 |
|
Oral SERDs for Breast Cancer — Year in Review Series on Relevant New Datasets and Advances
|
Apr 30, 2026 |
|
EGFR-Mutant Non-Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances
|
Apr 27, 2026 |
|
Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancers — Microlearning Activity 3: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium
|
Apr 24, 2026 |
|
Prostate Cancer — Year in Review Series on Relevant New Datasets and Advances
|
Apr 23, 2026 |
|
Acute Myeloid Leukemia — Year in Review Series on Relevant New Datasets and Advances
|
Apr 20, 2026 |
|
Lung Cancer — 5-Minute Journal Club with Dr Natalie Vokes: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays
|
Apr 17, 2026 |
|
HR-Positive Metastatic Breast Cancer — An Interview with Dr Seth Wander on Optimizing Biomarker Assessment and Related Treatment Decision-Making
|
Apr 16, 2026 |
|
Metastatic Bladder Cancer — Rapid Case Review Issue 4
|
Apr 15, 2026 |
|
ER-Positive, HER2-Positive Metastatic Breast Cancer — What Clinicians Want to Know About First-Line and Maintenance Therapy
|
Apr 14, 2026 |
|
Localized Colorectal Cancer — Microlearning Activity 2: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium
|
Apr 13, 2026 |
|
CELMoDs for Multiple Myeloma — Microlearning Activity 2 with Dr Paul G Richardson
|
Apr 10, 2026 |
|
HER2-Positive Gastrointestinal Cancers — Microlearning Activity 3: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium
|
Apr 08, 2026 |
|
Desmoid Tumors — Microlearning Activity 2 with Dr Ravin Ratan
|
Apr 07, 2026 |
|
Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancers — Microlearning Activity 2: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium
|
Apr 03, 2026 |
|
Nonmelanoma Skin Cancers — A Roundtable Discussion on the Multidisciplinary Management of Cutaneous Squamous Cell and Basal Cell Carcinomas
|
Apr 02, 2026 |
|
Immune Thrombocytopenia — Microlearning Activity 4 with Dr Hanny Al-Samkari: ASH 2025 Review
|
Apr 01, 2026 |
|
AKT Inhibition in Prostate Cancer — Proceedings from a Session Held Adjunct to the 2026 ASCO Genitourinary Cancers Symposium
|
Mar 30, 2026 |
|
Diabetology in Breast Cancer — Managing Hyperglycemia in Patients with Breast Cancer Receiving Agents Targeting the PI3K/AKT/PTEN Pathway
|
Mar 28, 2026 |
|
Metastatic Bladder Cancer — Rapid Case Review Issue 3
|
Mar 27, 2026 |
|
Localized Colorectal Cancer — Microlearning Activity 1: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium
|
Mar 26, 2026 |
|
Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Proceedings from a Session Held Adjunct to the 2026 ASCO Genitourinary Cancers Symposium
|
Mar 25, 2026 |
|
Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancers — Microlearning Activity 1: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium
|
Mar 24, 2026 |
|
CELMoDs for Multiple Myeloma — Microlearning Activity 1 with Dr Paul G Richardson
|
Mar 23, 2026 |
|
Immune Thrombocytopenia — Microlearning Activity 3 with Dr Hanny Al-Samkari: ASH 2025 Review
|
Mar 21, 2026 |
|
HER2-Positive Gastrointestinal Cancers — Microlearning Activity 2: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium
|
Mar 19, 2026 |
|
Breast Cancer — 5-Minute Journal Club Issue 2 with Dr Lajos Pusztai: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays
|
Mar 18, 2026 |
|
Desmoid Tumors — Microlearning Activity 1 with Dr Ravin Ratan
|
Mar 16, 2026 |
|
HER2-Positive Gastrointestinal Cancers — Microlearning Activity 1: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium
|
Mar 14, 2026 |
|
CD19 x CD3 BiTEs for Acute Lymphoblastic Leukemia — An Interview with Dr Bijal Shah
|
Mar 12, 2026 |
|
Chronic Lymphocytic Leukemia — An Interview with Prof Constantine Tam on Key Presentations from the 2025 ASH Annual Meeting
|
Mar 10, 2026 |
|
Immune Thrombocytopenia — Microlearning Activity 2 with Dr Hanny Al-Samkari: ASH 2025 Review
|
Mar 09, 2026 |
|
Ovarian Cancer — Year in Review Series on Relevant New Datasets and Advances
|
Mar 07, 2026 |
|
Oncology Nursing Update: Colorectal Cancer — An Interview with Dr Christopher Lieu on Molecular Residual Disease Analysis
|
Mar 06, 2026 |
|
Immune Thrombocytopenia — Microlearning Activity 1 with Dr Hanny Al-Samkari: ASH 2025 Review
|
Mar 03, 2026 |
|
Antibody-Drug Conjugates for Breast Cancer — Year in Review Series on Relevant New Datasets and Advances
|
Feb 28, 2026 |
|
Extensive-Stage Small Cell Lung Cancer — Current Patterns of Care with First-Line and Maintenance Therapy
|
Feb 27, 2026 |
|
Colorectal Cancer — A Roundtable Discussion on the Use of Molecular Residual Disease Analysis
|
Feb 26, 2026 |
|
Urothelial Bladder Cancer — Microlearning Activity 2 with Dr Terence Friedlander: ESMO Congress 2025 Review
|
Feb 23, 2026 |
|
Multiple Myeloma: Inside the Issue of Cereblon E3 Ligase Modulators
|
Feb 18, 2026 |
|
Metastatic Bladder Cancer — Rapid Case Review Issue 2
|
Feb 17, 2026 |
|
Gynecologic Cancers — Highlights from the 2025 ESMO Annual Meeting
|
Feb 16, 2026 |
|
Relapsed/Refractory Multiple Myeloma — Microlearning Activity 2 with Dr Sagar Lonial: ASH 2025 Review
|
Feb 13, 2026 |
|
Squamous Cell Carcinoma of the Anal Canal — An Interview with Dr Marwan Fakih
|
Feb 11, 2026 |
|
Prostate Cancer — Microlearning Activity 2 with Dr Rana R McKay: ESMO Congress 2025 Review
|
Feb 10, 2026 |
|
Antibody-Drug Conjugates for Ovarian Cancer — An Interview with Dr Kathleen N Moore
|
Feb 09, 2026 |
|
Localized Colorectal Cancer — Proceedings from a Session Held Adjunct to the 2026 ASCO Gastrointestinal Cancers Symposium
|
Feb 07, 2026 |
|
Immune Thrombocytopenia — ASH 2025 Review
|
Feb 06, 2026 |
|
Urothelial Bladder Cancer — Microlearning Activity 1 with Dr Terence Friedlander: ESMO Congress 2025 Review
|
Feb 04, 2026 |
|
Relapsed/Refractory Multiple Myeloma — Microlearning Activity 1 with Dr Sagar Lonial: ASH 2025 Review
|
Feb 03, 2026 |
|
Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancers — Proceedings from a Session Held Adjunct to the 2026 ASCO Gastrointestinal Cancers Symposium
|
Feb 02, 2026 |
|
Prostate Cancer — Microlearning Activity 1 with Dr Rana R McKay: ESMO Congress 2025 Review
|
Jan 29, 2026 |
|
HER2-Positive Gastrointestinal Cancers — Proceedings from a Session Held Adjunct to the 2026 ASCO Gastrointestinal Cancers Symposium
|
Jan 28, 2026 |
|
Endocrine-Based Therapy for HR-Positive Breast Cancer — Proceedings from a San Antonio 2025 Symposium Series
|
Jan 27, 2026 |
|
Metastatic Bladder Cancer — Rapid Case Review Issue 1
|
Jan 23, 2026 |
|
Bispecific Antibodies in the Management of Lymphoma — ASH 2025 Review
|
Jan 21, 2026 |
|
Relapsed/Refractory Multiple Myeloma — ASH 2025 Review
|
Jan 16, 2026 |
|
HER2-Positive Breast Cancer — Proceedings from a San Antonio 2025 Symposium Series
|
Jan 14, 2026 |
|
Follicular Lymphoma and Diffuse Large B-Cell Lymphoma — Proceedings from a Symposium Series Preceding the 67th ASH Annual Meeting and Exposition
|
Jan 13, 2026 |
|
Colorectal Cancer — 5-Minute Journal Club Issue 2 with Dr Scott Kopetz: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays
|
Jan 12, 2026 |
|
Myelofibrosis and Systemic Mastocytosis — Proceedings from a Symposium Series Preceding the 67th ASH Annual Meeting and Exposition
|
Jan 09, 2026 |
|
Antibody-Drug Conjugates for Breast Cancer — Proceedings from a San Antonio 2025 Symposium Series
|
Jan 08, 2026 |
|
Chronic Lymphocytic Leukemia — Proceedings from a Symposium Series Preceding the 67th ASH Annual Meeting and Exposition
|
Jan 07, 2026 |
|
Colorectal Cancer — 5-Minute Journal Club Issue 1 with Dr Scott Kopetz: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays
|
Jan 06, 2026 |
|
Acute Myeloid Leukemia — Proceedings from a Symposium Series Preceding the 67th ASH Annual Meeting and Exposition
|
Jan 03, 2026 |
|
Toxicities Associated with Antibody-Drug Conjugates for Metastatic Breast Cancer — Clinical Investigator Perspectives on Actual Patient Cases
|
Dec 23, 2025 |
|
Advanced Gastroesophageal Cancers — Expert Perspectives on Actual Patient Cases: Part 2 of 2
|
Dec 22, 2025 |
|
Urothelial Bladder Cancer and Prostate Cancer — Highlights from the 2025 ESMO Annual Meeting
|
Dec 19, 2025 |
|
Extensive-Stage Small Cell Lung Cancer — What Clinicians Want to Know About First-Line and Maintenance Therapy
|
Dec 17, 2025 |
|
Gastroesophageal Cancers — Proceedings from a Symposium Held in Partnership with the American Oncology Network
|
Dec 13, 2025 |
|
Ovarian Cancer — Proceedings from a Symposium Held in Partnership with the American Oncology Network
|
Dec 13, 2025 |
|
Chronic Lymphocytic Leukemia — Proceedings from a Symposium Held in Partnership with the American Oncology Network
|
Dec 12, 2025 |
|
Lung Cancer — Proceedings from a Symposium Held in Partnership with the American Oncology Network
|
Dec 12, 2025 |
|
CAR T-Cell Therapy for Non-Hodgkin Lymphoma | Cancer Q&A — Discussing Common Questions Posed by Patients
|
Dec 11, 2025 |
|
HER2-Altered Non-Small Cell Lung Cancer — An Interview with Dr John V Heymach
|
Dec 09, 2025 |
|
Breast Cancer — Highlights from the 2025 ESMO Annual Meeting
|
Dec 08, 2025 |
|
Breast Cancer — Microlearning Activity Issue 3 with Dr Priyanka Sharma: 2025 ESMO Annual Meeting Updates
|
Dec 05, 2025 |
|
Toxicities Associated with CAR T-Cell Therapy — An Interview with Dr Matthew Lunning
|
Dec 03, 2025 |
|
Breast Cancer — Microlearning Activity 2 with Dr Priyanka Sharma: 2025 ESMO Annual Meeting Updates
|
Dec 02, 2025 |
|
Metastatic Breast Cancer — Optimizing the Use of Oral Selective Estrogen Receptor Degraders: Part 2
|
Nov 29, 2025 |
|
Breast Cancer — Microlearning Activity 1 with Dr Priyanka Sharma: 2025 ESMO Annual Meeting Updates
|
Nov 26, 2025 |
|
HER2-Positive Gastrointestinal Cancers — Clinical Investigator Perspectives on Actual Patient Cases
|
Nov 21, 2025 |
|
HR-Positive Metastatic Breast Cancer — An Interview with Dr Erika Hamilton on the Potential Role of PROTAC Estrogen Receptor Degraders
|
Nov 19, 2025 |
|
Patient Education Resource: Non-Hodgkin Lymphoma — Clinical Experts Address Common Questions Posed by Patients About CAR T-Cell Therapy
|
Nov 15, 2025 |
|
ER-Positive Metastatic Breast Cancer — A Roundtable Discussion on the Current and Future Role of Oral SERDs
|
Nov 14, 2025 |
|
Diffuse Large B-Cell Lymphoma and Follicular Lymphoma — Proceedings from a Multitumor Symposium in Partnership with Florida Cancer Specialists & Research Institute
|
Nov 13, 2025 |
|
Colorectal Cancer — Proceedings from a Multitumor Symposium in Partnership with Florida Cancer Specialists & Research Institute
|
Nov 12, 2025 |
|
Prostate Cancer — Proceedings from a Multitumor Symposium in Partnership with Florida Cancer Specialists & Research Institute
|
Nov 11, 2025 |
|
Breast Cancer — Proceedings from a Multitumor Symposium in Partnership with Florida Cancer Specialists & Research Institute
|
Nov 10, 2025 |
|
Lung Cancer — 5-Minute Journal Club Issue 4 with Dr Aaron Lisberg: Defining the Role of TROP2-Directed Antibody-Drug Conjugates
|
Nov 07, 2025 |
|
Endometrial Cancer — Clinical Investigator Perspectives on Actual Patient Cases
|
Nov 06, 2025 |
|
ER-Positive Metastatic Breast Cancer — An Interview with Prof Patrick Neven on the Role of Oral Selective Estrogen Receptor Degraders
|
Nov 03, 2025 |
|
Colorectal Cancer — An Interview with Dr John Strickler on Molecular Residual Disease Analysis
|
Oct 29, 2025 |
|
Breast Cancer — 5-Minute Journal Club Issue 4 with Dr Kevin Kalinsky: Defining the Role of TROP2-Directed Antibody-Drug Conjugates
|
Oct 24, 2025 |
|
Acute Myeloid Leukemia — An Interview with Dr Eunice S Wang to Review Key Presentations from ASCO and EHA
|
Oct 22, 2025 |
|
Metastatic Breast Cancer — Current and Future Integration of Antibody-Drug Conjugates
|
Oct 20, 2025 |
|
Lung Cancer — 5-Minute Journal Club Issue 3 with Dr Aaron Lisberg: Defining the Role of TROP2-Directed Antibody-Drug Conjugates
|
Oct 18, 2025 |
|
Non-Hodgkin Lymphoma — The Implications of Recent Datasets for Current and Future Disease Management
|
Oct 17, 2025 |
|
HR-Positive and Triple-Negative Metastatic Breast Cancer — An Interview with Dr Laura Huppert on Optimal Integration of ADCs into Treatment
|
Oct 13, 2025 |
|
Follicular Lymphoma — Proceedings from a Session Held During the Society of Hematologic Oncology 2025 Annual Meeting
|
Oct 10, 2025 |
|
Acute Myeloid Leukemia — An Interview with Dr Ghayas Issa on the Role of Menin Inhibitors
|
Oct 08, 2025 |
|
Breast Cancer — An ASCO 2025 Review
|
Oct 06, 2025 |
|
Relapsed/Refractory Multiple Myeloma — Proceedings from a Session Held During the Society of Hematologic Oncology 2025 Annual Meeting
|
Oct 02, 2025 |
|
Breast Cancer — 5-Minute Journal Club Issue 3 with Dr Kevin Kalinsky: Defining the Role of TROP2-Directed Antibody-Drug Conjugates
|
Sep 26, 2025 |
|
Metastatic BRCA-Negative, Triple-Negative Breast Cancer — An Interview with Prof Peter Schmid on Optimal Management
|
Sep 22, 2025 |
|
Extrapulmonary Neuroendocrine Carcinoma — An Interview with Dr Jonathan Strosberg on Current and Future Management
|
Sep 20, 2025 |
|
Oncology Nursing Update: Multiple Myeloma — An Interview with Dr Beth Faiman on CAR T-Cell Therapy
|
Sep 19, 2025 |
|
Metastatic Triple-Negative Breast Cancer — The Selection and Sequencing of Therapy
|
Sep 17, 2025 |
|
Ocular Toxicities Associated with Antibody-Drug Conjugates and Other Cancer Therapies: Part 2 — An Interview with Dr Neel Pasricha on Adverse Event Management
|
Sep 16, 2025 |
|
Ocular Toxicities Associated with Antibody-Drug Conjugates and Other Cancer Therapies: Part 1 — Inside the Issue of Adverse Event Management
|
Sep 15, 2025 |
|
Non-Small Cell Lung Cancer — 5-Minute Journal Club Issue 2 with Dr Jacob Sands: Defining the Role of TROP2-Directed Antibody-Drug Conjugates
|
Sep 12, 2025 |
|
Metastatic Breast Cancer — Optimizing the Use of Oral Selective Estrogen Receptor Degraders: Part 1
|
Sep 08, 2025 |
|
Oncology Nursing Update: Newly Diagnosed Multiple Myeloma — An Interview with Ms Charise Gleason
|
Sep 06, 2025 |
|
Oncology Nursing Update: Newly Diagnosed Multiple Myeloma — An Interview with Prof Xavier Leleu
|
Sep 05, 2025 |
|
Breast Cancer — 5-Minute Journal Club Issue 2 with Dr Erika Hamilton: Defining the Role of TROP2-Directed Antibody-Drug Conjugates
|
Sep 01, 2025 |
|
Relapsed/Refractory Multiple Myeloma — Oncology Q&A: Discussing Common Questions Posed by Patients
|
Aug 29, 2025 |
|
Biliary Tract Cancers — Expert Perspectives on Actual Patient Cases: Part 2 of 2
|
Aug 28, 2025 |
|
Brain Metastases with HER2-Positive Breast Cancer — An Interview with Dr Sarah Sammons on Optimal Management Approaches
|
Aug 25, 2025 |
|
Small Cell Lung Cancer — Expert Perspectives on Actual Patient Cases
|
Aug 22, 2025 |
|
Ovarian and Endometrial Cancer — An Interview with Dr Shannon Westin on the Current Management Paradigm
|
Aug 20, 2025 |
|
Non-Small Cell Lung Cancer — 5-Minute Journal Club Issue 1 with Dr Jacob Sands: Defining the Role of TROP2-Directed Antibody-Drug Conjugates
|
Aug 15, 2025 |
|
Multiple Myeloma | Oncology Q&A — Patient Education Resource: Clinical Experts Address Common Questions Posed by Patients with Relapsed/Refractory Multiple Myeloma
|
Aug 14, 2025 |
|
Acute Myeloid Leukemia — An Interview with Dr Jorge Cortes on Optimal Management of FLT3 and IDH1/2 Mutations
|
Aug 11, 2025 |
|
Non-Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances
|
Aug 07, 2025 |
|
Multiple Myeloma — Optimizing the Selection of First-Line Therapy
|
Aug 06, 2025 |
|
Breast Cancer — 5-Minute Journal Club Issue 1 with Dr Erika Hamilton: Defining the Role of TROP2-Directed Antibody-Drug Conjugates
|
Aug 01, 2025 |
|
Gynecologic Cancers — Year in Review Series on Relevant New Datasets and Advances
|
Jul 31, 2025 |
|
Oncology Nursing Update: Prostate Cancer — An Interview with Ms Kathleen D Burns on the Current Treatment Paradigm and New Approaches to Patient Care
|
Jul 30, 2025 |
|
Endocrine-Resistant HR-Positive Metastatic Breast Cancer — An Interview with Dr Hope S Rugo on Optimal Management
|
Jul 28, 2025 |
|
Soft Tissue Sarcoma and Other Connective Tissue Neoplasms — Proceedings from a Webinar Held in Conjunction with the 2025 ASCO Annual Meeting
|
Jul 24, 2025 |
|
Renal Cell Carcinoma — Proceedings from a Webinar Held in Conjunction with the 2025 ASCO Annual Meeting
|
Jul 23, 2025 |
|
Chronic Lymphocytic Leukemia — Proceedings from a Session Held During the 2025 ASCO Annual Meeting
|
Jul 21, 2025 |
|
Oncology Nursing Update: Ovarian Cancer — An Interview with Ms Jennifer Filipi on the Current Treatment Paradigm and New Approaches
|
Jul 18, 2025 |
|
Multiple Myeloma — Proceedings from a Webinar Held in Conjunction with the 2025 ASCO Annual Meeting
|
Jul 17, 2025 |
|
Lung Cancer — Proceedings from a Session Held During the 2025 ASCO Annual Meeting on the Current and Future Role of Immunotherapy and Antibody-Drug Conjugates
|
Jul 16, 2025 |
|
For Oncology Nurses: Prostate Cancer — Proceedings from the 2025 Annual ONS Congress
|
Jul 15, 2025 |
|
HER2-Positive Gastrointestinal Cancers — Proceedings from a Session Held During the 2025 ASCO Annual Meeting
|
Jul 14, 2025 |
|
For Oncology Nurses: Chronic Lymphocytic Leukemia — Proceedings from the 2025 Annual ONS Congress
|
Jul 11, 2025 |
|
Urothelial Bladder Cancer — Proceedings from a Session Held During the 2025 ASCO Annual Meeting
|
Jul 10, 2025 |
|
Non-Hodgkin Lymphoma — Proceedings from a Session Held During the 2025 ASCO Annual Meeting
|
Jul 09, 2025 |
|
For Oncology Nurses: DLL3-Targeting Bispecific T-Cell Engagers for Small Cell Lung Cancer — Proceedings from the 2025 Annual ONS Congress
|
Jul 07, 2025 |
|
For Oncology Nurses: Non-Hodgkin Lymphoma — Proceedings from the 2025 Annual ONS Congress
|
Jul 04, 2025 |
|
Metastatic Breast Cancer — Proceedings from a Session Held During the 2025 ASCO Annual Meeting
|
Jul 03, 2025 |
|
Colorectal Cancer — Proceedings from a Session Held During the 2025 ASCO Annual Meeting
|
Jul 02, 2025 |
|
Ovarian and Endometrial Cancer — Proceedings from a Session Held During the 2025 ASCO Annual Meeting
|
Jun 30, 2025 |
|
For Oncology Nurses: Chronic Myeloid Leukemia — Proceedings from the 2025 Annual ONS Congress
|
Jun 27, 2025 |
|
Prostate Cancer — Proceedings from a Session Held During the 2025 ASCO Annual Meeting
|
Jun 25, 2025 |
|
For Oncology Nurses: Ovarian Cancer — Proceedings from the 2025 Annual ONS Congress
|
Jun 24, 2025 |
|
IDH-Mutant Low-Grade Glioma — An Interview with Dr Patrick Y Wen on Current and Future Management Strategies
|
Jun 23, 2025 |
|
EGFR Mutation-Positive Non-Small Cell Lung Cancer — Proceedings from a Session Held During the 2025 ASCO Annual Meeting
|
Jun 20, 2025 |
|
Advanced Gastroesophageal Cancers — Expert Perspectives on Actual Patient Cases: Part 1 of 2
|
Jun 18, 2025 |
|
Multiple Myeloma — Year in Review Series on Relevant New Datasets and Advances
|
Jun 17, 2025 |
|
For Oncology Nurses: Hormone Receptor-Positive Breast Cancer — Proceedings from the 2025 Annual ONS Congress
|
Jun 16, 2025 |
|
For Oncology Nurses: Gastroesophageal Cancer — Proceedings from the 2025 Annual ONS Congress
|
Jun 12, 2025 |
|
Myelofibrosis — Year in Review Series on Relevant New Datasets and Advances
|
Jun 11, 2025 |
|
Non-Small Cell Lung Cancer and Therapeutic Targets Beyond EGFR — Year in Review Series on Relevant New Datasets and Advances
|
Jun 09, 2025 |
|
For Oncology Nurses: Endometrial Cancer — Proceedings from the 2025 Annual ONS Congress
|
Jun 06, 2025 |
|
Non-Hodgkin Lymphoma — Year in Review Series on Relevant New Datasets and Advances
|
Jun 05, 2025 |
|
Breast Cancer: Additional Perspectives — Year in Review Series on Relevant New Datasets and Advances
|
Jun 04, 2025 |
|
Prostate Cancer and AKT Inhibitors — Proceedings from a Session Held During the American Urological Association Annual Meeting
|
Jun 03, 2025 |
|
Systemic Mastocytosis and Myelofibrosis — Fourth Annual National General Medical Oncology Summit
|
Jun 02, 2025 |
|
Hepatocellular Carcinoma — Fourth Annual National General Medical Oncology Summit
|
Jun 01, 2025 |
|
Multiple Myeloma — Fourth Annual National General Medical Oncology Summit
|
May 31, 2025 |
|
For Oncology Nurses: Pancreatic Cancer — Proceedings from the 2025 Annual ONS Congress
|
May 30, 2025 |
|
Multiple Myeloma — An Interview with Dr Rafael Fonseca on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting
|
May 28, 2025 |
|
5-Minute Journal Club Issue 8 with Dr Rinath M Jesselsohn: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer
|
May 27, 2025 |
|
Gastroesophageal Cancer — Fourth Annual National General Medical Oncology Summit
|
May 26, 2025 |
|
Chronic Lymphocytic Leukemia — An Interview with Dr Lindsey Roeker on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting
|
May 24, 2025 |
|
Relapsed/Refractory Follicular Lymphoma Part 3 — A Roundtable Discussion on the Selection and Sequencing of Other Novel Therapies
|
May 23, 2025 |
|
Urothelial Bladder Cancer — Fourth Annual National General Medical Oncology Summit
|
May 22, 2025 |
|
Pancreatic Cancer — Fourth Annual National General Medical Oncology Summit
|
May 21, 2025 |
|
Non-Hodgkin Lymphoma — An Interview with Dr Jennifer Crombie on the Use of Bispecific Antibodies
|
May 20, 2025 |
|
5-Minute Journal Club Issue 7 with Dr Rinath M Jesselsohn: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer
|
May 19, 2025 |
|
Immunotherapy and Nontargeted Approaches for NSCLC — Fourth Annual National General Medical Oncology Summit
|
May 18, 2025 |
|
Colorectal Cancer — Fourth Annual National General Medical Oncology Summit
|
May 17, 2025 |
|
Relapsed/Refractory Follicular Lymphoma Part 2 — A Roundtable Discussion on the Selection and Sequencing of CAR T-Cell Therapy
|
May 16, 2025 |
|
Prostate Cancer — Year in Review Series on Relevant New Datasets and Advances
|
May 14, 2025 |
|
Non-Hodgkin Lymphoma — Fourth Annual National General Medical Oncology Summit
|
May 12, 2025 |
|
Gynecologic Cancers — Fourth Annual National General Medical Oncology Summit
|
May 11, 2025 |
|
Non-Hodgkin Lymphoma — An Interview with Dr John P Leonard on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting
|
May 09, 2025 |
|
Breast Cancer — Year in Review Series on Relevant New Datasets and Advances
|
May 05, 2025 |
|
Chronic Lymphocytic Leukemia — Year in Review Series on Relevant New Datasets and Advances
|
May 02, 2025 |
|
EGFR Mutation-Positive NSCLC — Fourth Annual National General Medical Oncology Summit
|
Apr 30, 2025 |
|
Prostate Cancer — Fourth Annual National General Medical Oncology Summit
|
Apr 29, 2025 |
|
Immune Thrombocytopenia — A Roundtable Discussion on Current and Future Management Strategies
|
Apr 28, 2025 |
|
Biliary Tract Cancers — Fourth Annual National General Medical Oncology Summit
|
Apr 27, 2025 |
|
For Oncology Nurses: Antibody-Drug Conjugates for Breast Cancer and Lung Cancer — Proceedings from the 2025 Annual ONS Congress
|
Apr 26, 2025 |
|
Hormone Receptor-Positive Metastatic Breast Cancer — An Interview with Dr Adam M Brufsky on the Impact of Biomarkers and Existing Comorbidities on the Selection of First-Line Therapy
|
Apr 23, 2025 |
|
Genitourinary Cancers — An Interview with Dr William K Oh on Recent Trial Updates
|
Apr 23, 2025 |
|
Relapsed/Refractory Follicular Lymphoma Part 1 — A Roundtable Discussion on the Selection and Sequencing of Bispecific Antibodies
|
Apr 22, 2025 |
|
HER2-Positive and Triple-Negative Breast Cancer — Fourth Annual National General Medical Oncology Summit
|
Apr 21, 2025 |
|
Oncology Nursing Update Special 2-Part Edition: Bispecific Antibodies in Lymphoma — Part 2
|
Apr 18, 2025 |
|
Ovarian Cancer — Proceedings from a Session Held During the 2025 Society of Gynecologic Oncology Annual Meeting on Women’s Cancer®️
|
Apr 17, 2025 |
|
Myelofibrosis — An Interview with Dr Raajit K Rampal on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting
|
Apr 15, 2025 |
|
Sarcoma and Other Connective Tissue Neoplasms — Fourth Annual National General Medical Oncology Summit
|
Apr 14, 2025 |
|
HR-Positive Breast Cancer — Fourth Annual National General Medical Oncology Summit
|
Apr 13, 2025 |
|
Chronic Lymphocytic Leukemia — Fourth Annual National General Medical Oncology Summit
|
Apr 12, 2025 |
|
Neuroendocrine Tumors — Fourth Annual National General Medical Oncology Summit
|
Apr 11, 2025 |
|
First-Line Therapy for Metastatic Non-Small Cell Lung Cancer and an ALK Rearrangement — An Interview with Dr Justin F Gainor
|
Apr 09, 2025 |
|
Breast Cancer — An Interview with Dr Adrienne G Waks on Recent Trial Updates
|
Apr 07, 2025 |
|
Chronic Lymphocytic Leukemia — An Interview with Dr Catherine C Coombs on Real-World Cases and Current Questions and Controversies Presented at Recent Conferences
|
Apr 03, 2025 |
|
HER2-Positive Gynecologic Cancers — Proceedings from a Session Held During the 2025 Society of Gynecologic Oncology Annual Meeting on Women’s Cancer®️
|
Apr 02, 2025 |
|
HR-Positive Breast Cancer — An Interview with Dr Sara A Hurvitz on the Role of Endocrine-Based Therapy
|
Mar 27, 2025 |
|
For Oncology Nurses: Bispecific Antibodies in Multiple Myeloma — An Interview with Dr Tiffany A Richards
|
Mar 24, 2025 |
|
5-Minute Journal Club Issue 6 with Dr Komal Jhaveri: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer
|
Mar 21, 2025 |
|
Neurofibromatosis Type 1 Plexiform Neurofibromas — An interview with Dr Christopher L Moertel
|
Mar 20, 2025 |
|
Oncology Nursing Update Special 2-Part Edition: Bispecific Antibodies in Lymphoma — Part 1
|
Mar 17, 2025 |
|
Renal Cell Carcinoma — Proceedings from a Session Held in Conjunction with the 2025 ASCO Genitourinary Cancers Symposium (ASCO GU)
|
Mar 14, 2025 |
|
Colorectal Cancer — Year in Review Series on Relevant New Datasets and Advances
|
Mar 13, 2025 |
|
Localized Breast Cancer — Examining the Current Use of Genetic Testing and Related Clinical Management
|
Mar 11, 2025 |
|
Urothelial Bladder Cancer and Prostate Cancer — Proceedings from a Session Held in Conjunction with the 2025 ASCO Genitourinary Cancers Symposium (ASCO GU)
|
Mar 06, 2025 |
|
5-Minute Journal Club Issue 5 with Dr Komal Jhaveri: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer
|
Feb 28, 2025 |
|
Biliary Tract Cancers — Reviewing Patient Cases with Prof John Bridgewater: Part 1 of 2
|
Feb 27, 2025 |
|
Relapsed/Refractory Diffuse Large B-Cell Lymphoma — A Roundtable Discussion on Current and Future Management Strategies
|
Feb 21, 2025 |
|
Colorectal Cancer — Proceedings from a Session Held in Conjunction with the 2025 ASCO Gastrointestinal Cancers Symposium (ASCO GI)
|
Feb 20, 2025 |
|
Multiple Myeloma — An Interview with Dr Surbhi Sidana on Optimizing the Role of CAR T-Cell Therapy
|
Feb 18, 2025 |
|
HER2-Low and HER2-Ultralow Breast Cancer — A Roundtable Discussion on Current and Future Management Strategies
|
Feb 14, 2025 |
|
Hepatocellular Carcinoma — Proceedings From a Session Held in Conjunction with the 2025 ASCO Gastrointestinal Cancers Symposium (ASCO GI)
|
Feb 12, 2025 |
|
5-Minute Journal Club Issue 4 with Dr Seth Wander: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer
|
Feb 07, 2025 |
|
EGFR-Mutant Non-Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances
|
Feb 05, 2025 |
|
Multiple Myeloma — Optimizing the Selection of First-Line Therapy with Dr Saad Zafar Usmani
|
Feb 03, 2025 |
|
5-Minute Journal Club Issue 3 with Dr Seth Wander: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer
|
Jan 31, 2025 |
|
Chronic Lymphocytic Leukemia with Dr Jennifer Woyach: Part 3 of a 3-Part Meet The Professor Series
|
Jan 29, 2025 |
|
Metastatic Triple-Negative Breast Cancer — Oncology Q&A for Clinicians: Discussing Common Questions Posed by Patients
|
Jan 24, 2025 |
|
Data + Perspectives: Clinical Investigators Discuss the Role of CAR T-Cell Therapy for Patients with Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia
|
Jan 22, 2025 |
|
Oncology Q&A for Patients with Metastatic Triple-Negative Breast Cancer
|
Jan 17, 2025 |
|
CAR T-Cell and Bispecific Therapy for Lymphoma — Part 3 of Our 6-Part ASH 2024 Friday Satellite Symposia Series
|
Jan 15, 2025 |
|
Myelofibrosis — Part 4 of Our 6-Part ASH 2024 Friday Satellite Symposia Series
|
Jan 13, 2025 |
|
Metastatic Breast Cancer — San Antonio 2024 symposium series proceedings Part 3
|
Jan 10, 2025 |
|
Chronic Myeloid Leukemia — Part 1 of Our 6-Part ASH 2024 Friday Satellite Symposia Series
|
Jan 08, 2025 |
|
Acute Myeloid Leukemia — Part 5 of Our 6-Part ASH 2024 Friday Satellite Symposia Series
|
Jan 06, 2025 |
|
The Role of Endocrine-Based Therapy in the Management of Breast Cancer — San Antonio 2024 symposium series proceedings Part 2
|
Jan 03, 2025 |
|
HER2-Low and HER2-Ultralow Breast Cancer — San Antonio 2024 symposium series proceedings Part 1
|
Dec 23, 2024 |
|
Multiple Myeloma — Part 6 of Our 6-Part ASH 2024 Friday Satellite Symposia Series
|
Dec 20, 2024 |
|
Chronic Lymphocytic Leukemia — Part 2 of Our 6-Part ASH 2024 Friday Satellite Symposia Series
|
Dec 18, 2024 |
|
Cases from the Community: Integrating New Research Findings into Current Practice — Colorectal and Gastroesophageal Cancers
|
Dec 18, 2024 |
|
Cases from the Community: Integrating New Research Findings into Current Practice — Hepatobiliary Cancers
|
Dec 18, 2024 |
|
Cases from the Community: Integrating New Research Findings into Current Practice — Gynecologic Cancers
|
Dec 17, 2024 |
|
Cases from the Community: Integrating New Research Findings into Current Practice — Myelofibrosis
|
Dec 17, 2024 |
|
Cases from the Community: Integrating New Research Findings into Current Practice — Leukemia and Myelodysplastic Syndromes
|
Dec 13, 2024 |
|
Cases from the Community: Integrating New Research Findings into Current Practice — Lung Cancer
|
Dec 13, 2024 |
|
5-Minute Journal Club Issue 2 with Dr Seth Wander: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer
|
Dec 13, 2024 |
|
Meet The Professor: Current and Future Use of Nontargeted Therapy for Metastatic Non-Small Cell Lung Cancer — A 2024 World Conference on Lung Cancer Review
|
Dec 10, 2024 |
|
Exploring the Current Management Paradigm for Patients with Metastatic Triple-Negative Breast Cancer
|
Dec 04, 2024 |
|
Practical Perspectives: Investigators Discuss the Current Management of Paroxysmal Nocturnal Hemoglobinuria
|
Dec 03, 2024 |
|
Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care — Multiple Myeloma
|
Nov 26, 2024 |
|
5-Minute Journal Club Issue 1 with Dr Seth Wander: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer
|
Nov 25, 2024 |
|
The Implications of Recent Datasets for the Current and Future Management of Lung Cancer — A Review of Information from ESMO Congress 2024 and Other Conferences
|
Nov 22, 2024 |
|
Meet The Professor: Optimizing the Management of Chronic Lymphocytic Leukemia — Part 2 of a 3-Part Series
|
Nov 22, 2024 |
|
Optimizing the Management of Tenosynovial Giant Cell Tumor
|
Nov 20, 2024 |
|
Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care — Prostate Cancer
|
Nov 20, 2024 |
|
Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care — Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia
|
Nov 20, 2024 |
|
Optimizing Therapy for Patients with Hormone Receptor-Positive Metastatic Breast Cancer Harboring PI3K/AKT/PTEN Pathway Abnormalities
|
Nov 18, 2024 |
|
Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care — Lung Cancer
|
Nov 15, 2024 |
|
Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care — Breast Cancer
|
Nov 15, 2024 |
|
What Clinicians Want to Know About the Current and Future Role of EZH1/2 Inhibitors in the Care of Patients with Lymphoma
|
Nov 08, 2024 |
|
Special Edition — Key Presentations on Lung Cancer from Recent Major Conferences
|
Nov 06, 2024 |
|
The Implications of Recent Datasets for the Current and Future Management of Gastrointestinal Cancers — An ESMO Congress 2024 Review
|
Nov 05, 2024 |
|
Improving Outcomes with First-Line Endocrine-Based Therapy for Patients with HR-Positive, HER2-Negative Metastatic Breast Cancer
|
Nov 01, 2024 |
|
Practical Perspectives: Optimizing the Role of BTK Inhibitors in the Management of Mantle Cell Lymphoma
|
Oct 29, 2024 |
|
Potential Role of PROTAC ER Degraders in Therapy for HR-Positive Metastatic Breast Cancer
|
Oct 25, 2024 |
|
Practical Perspectives: Current Management of Chronic Myeloid Leukemia
|
Oct 23, 2024 |
|
The Implications of Recent Datasets for the Current and Future Management of Small Cell Lung Cancer — A 2024 World Conference on Lung Cancer Review
|
Oct 22, 2024 |
|
Practical Perspectives: Optimizing Diagnosis and Treatment for Patients with Desmoid Tumors
|
Oct 18, 2024 |
|
Peripheral T-Cell Lymphoma
|
Oct 16, 2024 |
|
The Implications of Recent Datasets for the Current and Future Use of Nontargeted Therapy for Metastatic Non-Small Cell Lung Cancer
|
Oct 15, 2024 |
|
Meet The Professor: Optimizing the Management of Chronic Lymphocytic Leukemia — Part 1 of a 3-Part Series
|
Oct 10, 2024 |
|
The Implications of Recent Datasets for the Current and Future Management of Non-Small Cell Lung Cancer with Actionable Targets Beyond EGFR
|
Oct 08, 2024 |
|
The Implications of Recent Datasets for the Current and Future Management of Non-Small Cell Lung Cancer with EGFR Mutations
|
Oct 01, 2024 |
|
Optimizing the Management of Metastatic BRCA-Negative, Triple-Negative Breast Cancer
|
Sep 24, 2024 |
|
Striving for Consensus: Optimizing the Current and Future Management of Biliary Tract Cancers
|
Sep 20, 2024 |
|
Inside the Issue: Optimizing the Diagnosis and Treatment of Neuroendocrine Tumors
|
Sep 17, 2024 |
|
Inside the Issue: Integrating HER2-Targeted Strategies into the Management of Gastrointestinal Cancers
|
Sep 11, 2024 |
|
Optimizing the Management of Dedifferentiated Liposarcoma
|
Sep 09, 2024 |
|
Inside the Issue: Integrating Antibody-Drug Conjugates into the Management of HR-Positive and Triple-Negative Metastatic Breast Cancer
|
Sep 06, 2024 |
|
Current and Future Management of Non-Small Cell Lung Cancer with an EGFR Mutation
|
Sep 04, 2024 |
|
Management of Metastatic Urothelial Bladder Cancer
|
Aug 30, 2024 |
|
Special Edition — Key Presentations on Breast Cancer from the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
|
Aug 28, 2024 |
|
An interview with Professor Giuseppe Curigliano, MD, PhD — Management of Metastatic Breast Cancer
|
Aug 23, 2024 |
|
An interview with Angeles Alvarez Secord, MD, MHSc — Management of Ovarian and Endometrial Cancer
|
Aug 21, 2024 |
|
Inside the Issue: Integrating ALK-Targeted Therapy into the Management of Localized Non-Small Cell Lung Cancer
|
Aug 20, 2024 |
|
Integrating Antibody-Drug Conjugates into the Management of HR-Positive and Triple-Negative Metastatic Breast Cancer
|
Aug 16, 2024 |
|
Novel Agents and Strategies in Lung Cancer
|
Aug 13, 2024 |
|
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Multiple Myeloma
|
Aug 09, 2024 |
|
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Melanoma and Nonmelanoma Skin Cancers
|
Aug 08, 2024 |
|
Individualizing the Selection of First-Line Therapy for Patients with Hormone Receptor-Positive Metastatic Breast Cancer
|
Aug 06, 2024 |
|
An interview with Matthew R Smith, MD, PhD — Management of Prostate Cancer
|
Aug 02, 2024 |
|
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Immunotherapy and Other Nontargeted Approaches for Lung Cancer
|
Jul 30, 2024 |
|
Optimizing the Identification of HER2-Low Breast Cancer
|
Jul 30, 2024 |
|
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Gynecologic Oncology
|
Jul 26, 2024 |
|
An interview with Jonathan W Goldman, MD — Management of Non-Small Cell Lung Cancer with an EGFR Mutation
|
Jul 24, 2024 |
|
Investigator Perspectives on Available Research and Challenging Questions in Melanoma and Nonmelanoma Skin Cancers: A Post-ASCO 2024 Annual Review
|
Jul 19, 2024 |
|
Investigator Perspectives on Available Research and Challenging Questions in Renal Cell Carcinoma: A Post-ASCO Annual Review
|
Jul 17, 2024 |
|
RTP Live from Chicago: Investigator Perspectives on Recent Advances and Challenging Questions in the Management of Colorectal Cancer
|
Jul 12, 2024 |
|
RTP Live from Chicago: Investigator Perspectives on the Role of Bispecific Antibodies in the Management of Lymphoma
|
Jul 12, 2024 |
|
What Clinicians Want to Know About the Management of Triple-Negative Breast Cancer
|
Jul 10, 2024 |
|
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Myelofibrosis
|
Jul 01, 2024 |
|
Clinical Update on the Current Management of Advanced Urothelial Bladder Cancer
|
Jun 17, 2024 |
|
Striving for Consensus: Exploring the Current Role of Ovarian Suppression in the Management of Breast Cancer
|
Jun 12, 2024 |
|
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Targeted Therapy for Non-Small Cell Lung Cancer
|
Jun 11, 2024 |
|
Second Opinion: Urologic Oncology Investigators Discuss How They Apply Clinical Research in the Care of Patients with Urothelial Bladder Cancer
|
Jun 07, 2024 |
|
Key Presentations on Lymphoma from Recent Major Conferences
|
May 28, 2024 |
|
Bispecific Antibodies in the Management of Multiple Myeloma
|
May 24, 2024 |
|
Recent Advances in the Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
|
May 24, 2024 |
|
Understanding the Risk of Recurrence and Related Management for Patients with Localized HER2-Positive Breast Cancer
|
May 20, 2024 |
|
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Acute Myeloid Leukemia
|
May 13, 2024 |
|
Virtual Case Library: Metastatic Triple-Negative Breast Cancer
|
May 08, 2024 |
|
Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Urothelial Bladder Cancer — Part 3 of a Special 3-Part Edition
|
May 06, 2024 |
|
Year in Review: Novel Treatments and Strategies in Gastroesophageal Cancer
|
May 03, 2024 |
|
Meet The Professor: Optimizing the Management of Myelofibrosis — Part 2 of a 2-Part Series
|
May 01, 2024 |
|
Striving for Consensus: Current and Future Management of Paroxysmal Nocturnal Hemoglobinuria
|
Apr 26, 2024 |
|
Special Edition – Prostate Cancer Updates from a CME Program Held at the 2024 Genitourinary Cancers Symposium
|
Apr 24, 2024 |
|
Key Presentations on Myeloproliferative Neoplasms from Recent Major Conferences
|
Apr 23, 2024 |
|
Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Gastrointestinal Cancers — Part 2 of a Special 3-Part Edition
|
Apr 15, 2024 |
|
Key Presentations on Chronic Lymphocytic Leukemia from Recent Major Conferences
|
Apr 12, 2024 |
|
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Colorectal Cancer
|
Apr 05, 2024 |
|
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Urothelial Bladder Cancer
|
Apr 05, 2024 |
|
The Emerging Role of B7-H3-Targeted Antibody-Drug Conjugates
|
Apr 03, 2024 |
|
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Prostate Cancer
|
Mar 27, 2024 |
|
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Lymphoma
|
Mar 26, 2024 |
|
Overcoming Endocrine Resistance in ER-Positive Metastatic Breast Cancer
|
Mar 25, 2024 |
|
Consensus or Controversy? Immune Checkpoint Inhibitors in the Management of Hepatobiliary Cancers — A 2024 Post-ASCO Gastrointestinal Cancers Symposium Review
|
Mar 21, 2024 |
|
Promising Therapeutic Strategies for Patients with Progressive Metastatic Non-Small Cell Lung Cancer
|
Mar 19, 2024 |
|
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in HER2-Positive and Triple-Negative Breast Cancer
|
Mar 15, 2024 |
|
Virtual Case Library: Metastatic Urothelial Bladder Cancer
|
Mar 13, 2024 |
|
Understanding the Current and Future Role of Oral SERDs (Selective Estrogen Receptor Degraders) in the Management of ER-Positive Metastatic Breast Cancer
|
Mar 11, 2024 |
|
Meet The Professor: Optimizing the Management of Myelofibrosis — Part 1 of a 2-Part Series
|
Mar 08, 2024 |
|
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Gastroesophageal Cancers
|
Mar 06, 2024 |
|
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Chronic Lymphocytic Leukemia
|
Feb 26, 2024 |
|
Consensus or Controversy? Investigator Perspectives on the Current and Future Role of Immune Checkpoint Inhibitors in the Management of Hepatobiliary Cancers
|
Feb 23, 2024 |
|
Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 4 of a 4-Part Series
|
Feb 16, 2024 |
|
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Hormone Receptor-Positive Breast Cancer
|
Jan 31, 2024 |
|
Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 3 of a 4-Part Series
|
Jan 23, 2024 |
|
Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes — Part 3 of a 3-Part Series
|
Jan 16, 2024 |
|
Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Gynecologic Cancers — Part 1 of a Special 3-Part Edition
|
Dec 19, 2023 |
|
Inside the Issue: Targeted and Immunotherapeutic Approaches for Biliary Tract Cancers
|
Dec 13, 2023 |
|
Implications of Recent Data Sets for the Current and Future Management of Lung Cancer
|
Dec 08, 2023 |
|
Meet The Professor: Optimizing the Management of Gastroesophageal Cancers — Part 3 of a 3-Part Series
|
Dec 05, 2023 |
|
Implications of Recent Data Sets for the Current and Future Management of Breast Cancer
|
Nov 29, 2023 |
|
Implications of Recent Data Sets for the Current and Future Management of Gynecologic Cancers
|
Nov 20, 2023 |
|
Meet The Professor: Optimizing the Management of Gastroesophageal Cancers — Part 2 of a 3-Part Series
|
Nov 14, 2023 |
|
Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes — Part 2 of a 3-Part Series
|
Nov 10, 2023 |
|
Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 2 of a 4-Part Series
|
Nov 01, 2023 |
|
Inside the Issue: Optimizing the Management of Nonmelanoma Skin Cancer
|
Oct 24, 2023 |
|
Meet The Professor: Optimizing the Management of Gastroesophageal Cancers — Part 1 of a 3-Part Series
|
Oct 20, 2023 |
|
Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes — Part 1 of a 3-Part Series
|
Oct 20, 2023 |
|
What Clinicians Want to Know About the Management of Relapsed/Refractory Mantle Cell Lymphoma
|
Oct 18, 2023 |
|
Key Presentations on Multiple Myeloma from Recent Major Oncology/Hematology Conferences
|
Oct 17, 2023 |
|
Inside the Issue: Integrating Targeted and Immunotherapy into the Management of Localized Non-Small Cell Lung Cancer
|
Oct 13, 2023 |
|
Management of Metastatic Pancreatic Cancer with Dr Michael Pishvaian
|
Oct 12, 2023 |
|
Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma with Dr Matthew Matasar
|
Oct 11, 2023 |
|
Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 1 of a 4-Part Series
|
Oct 09, 2023 |
|
What Clinicians Want to Know About Anti-CD38 Antibodies in the Management of Multiple Myeloma
|
Oct 06, 2023 |
|
Practical Perspectives: Investigators Discuss Current Management and Actual Cases of Relapsed/Refractory Metastatic Colorectal Cancer
|
Oct 06, 2023 |
|
Blastic Plasmacytoid Dendritic Cell Neoplasm
|
Oct 04, 2023 |
|
Inside the Issue: Optimizing the Management of Metastatic BRCA-Negative, Triple-Negative Breast Cancer
|
Sep 29, 2023 |
|
Emerging Role of CELMoDs (Cereblon E3 Ligase Modulators) and Other Novel Approaches to Targeting Protein Degradation Pathways in Multiple Myeloma
|
Sep 27, 2023 |
|
Novel Agents and Strategies in the Treatment of Ovarian Cancer
|
Sep 25, 2023 |
|
What Clinicians Want to Know About Toxicity Considerations Associated with BTK Inhibitors
|
Sep 22, 2023 |
|
Optimizing the Management of Metastatic Pancreatic Cancer
|
Sep 15, 2023 |
|
The Current and Future Role of CD20 x CD3 Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma
|
Sep 13, 2023 |
|
Meet The Professor: Optimizing the Management of Melanoma
|
Sep 11, 2023 |
|
Striving for Consensus: Current and Future Management of Metastatic Non-Small Cell Lung Cancer in Patients Who Experience Disease Progression on Immune Checkpoint Inhibitor Therapy
|
Sep 08, 2023 |
|
The Implications of Recent Data Sets for the Management of Hepatocellular Carcinoma
|
Sep 05, 2023 |
|
Exploring the Current and Future Management of High-Risk, Hormone-Sensitive Nonmetastatic Prostate Cancer
|
Sep 01, 2023 |
|
Role of BTK Inhibitors in Therapy for Mantle Cell Lymphoma
|
Aug 30, 2023 |
|
Meet The Professor: Optimizing the Management of Soft Tissue Sarcoma and Related Connective Tissue Disorders — Part 2 of a 2-Part Series
|
Aug 29, 2023 |
|
Special Edition — Key Presentations on Chronic Lymphocytic Leukemia and Lymphoma from Recent Major Oncology/Hematology Conferences
|
Aug 28, 2023 |
|
Special Edition — Key Presentations on Genitourinary Cancers from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
|
Aug 25, 2023 |
|
Current and Future Management of ER-Positive Metastatic Breast Cancer After Disease Progression on a CDK4/6 Inhibitor
|
Aug 23, 2023 |
|
Integrating Bispecific Antibodies into the Management of Multiple Myeloma — Patient Selection and Toxicity Management
|
Aug 22, 2023 |
|
Special Edition — Key Presentations on Lung Cancer from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
|
Aug 21, 2023 |
|
Special Nursing Edition — What I Tell My Patients About New Treatments and Clinical Trials in Chronic Lymphocytic Leukemia
|
Aug 18, 2023 |
|
Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Melanoma and Nonmelanoma Skin Cancers
|
Aug 16, 2023 |
|
Special Edition — Key Presentations from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, Gastrointestinal Cancers Issue
|
Aug 15, 2023 |
|
Special Edition — Key Presentations on Gynecologic Cancers from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
|
Aug 11, 2023 |
|
Ready for Prime Time? Determining the Current and Future Role of PARP Inhibitor-Based Combinations in the Management of Prostate Cancer — A Clinical Investigator Think Tank
|
Aug 11, 2023 |
|
Optimizing the Management of Metastatic Urothelial Bladder Cancer
|
Aug 09, 2023 |
|
Special Edition — Current and Future Management of Breast Cancer
|
Aug 08, 2023 |
|
Special Edition — Key Presentations from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, Ovarian Cancer Issue
|
Aug 03, 2023 |
|
Special Nursing Edition — What I Tell My Patients About New Treatments and Clinical Trials in Colorectal and Gastroesophageal Cancers
|
Aug 02, 2023 |
|
Novel Agents, Approaches and Strategies in the Management of Higher-Risk Myelodysplastic Syndromes
|
Aug 02, 2023 |
|
Immune Thrombocytopenia Edition with Dr Hanny Al-Samkari
|
Jul 28, 2023 |
|
Paroxysmal Nocturnal Hemoglobinuria Edition with Dr Carlos de Castro
|
Jul 25, 2023 |
|
Special Edition — Management of Hepatobiliary Cancers
|
Jul 24, 2023 |
|
Special Edition — Management of Urothelial Bladder Cancer
|
Jul 21, 2023 |
|
Special Edition — Current and Future Management of Breast Cancer
|
Jul 21, 2023 |
|
Special Nursing Edition — What I Tell My Patients About New Treatments and Clinical Trials in Urothelial Bladder Cancer
|
Jul 20, 2023 |
|
The Implications of New Research Findings for the Management of Endometrial Cancer
|
Jul 14, 2023 |
|
Meet The Professor: The Current and Future Management of Hodgkin and Non-Hodgkin Lymphoma
|
Jul 06, 2023 |
|
Meet The Professor: Optimizing the Management of Soft Tissue Sarcoma and Related Connective Tissue Disorders — Part 1 of a 2 - Part Series
|
Jun 16, 2023 |
|
Key Presentations from the 64th American Society of Hematology (ASH) Annual Meeting: Multiple Myeloma Edition
|
Apr 19, 2023 |
|
Key Presentations from the 64th American Society of Hematology (ASH) Annual Meeting: Chronic Lymphocytic Leukemia Edition
|
Apr 12, 2023 |
|
Key Presentations in Hodgkin and Non-Hodgkin Lymphomas from the 2022 ASH Annual Meeting with Dr Matthew Lunning
|
Mar 02, 2023 |
|
Management of Desmoid Tumors with Dr Mrinal Gounder
|
Feb 28, 2023 |
|
Management of HER2-Altered Non-Small Cell Lung Cancer
|
Feb 21, 2023 |
|
Management of Metastatic Non-Small Cell Lung Cancer without an Actionable Mutation
|
Feb 13, 2023 |
|
Key Presentations on Myeloproliferative Neoplasms from the 2022 ASH Annual Meeting — With Dr Srdan Verstovsek
|
Feb 09, 2023 |
|
Advances in Diffuse Large B-Cell Lymphoma with Dr Gilles Salles
|
Feb 06, 2023 |
|
Key Presentations in Acute Myeloid Leukemia and Myelodysplastic Syndromes from the 2022 ASH Annual Meeting with Dr Richard Stone
|
Feb 02, 2023 |
|
Special Edition — Management of ER-Positive Breast Cancer with Drs Erica Mayer and Ruth O'Regan
|
Jan 31, 2023 |
|
HER2-Positive Metastatic Breast Cancer with Professor Giuseppe Curigliano
|
Jan 26, 2023 |
|
Management of Gastroesophageal Cancers with Dr Manish Shah
|
Jan 12, 2023 |
|
Managing Metastatic Urothelial Bladder Cancer with Dr Scott Tagawa
|
Jan 05, 2023 |